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Abstract 
C10orf11 encodes a leucine-rich repeat protein 
having a role in melanocyte differentiation. 
Mutations in this gene have been associated with 
autosomal recessive oculocutaneous albinism 7 
(OCAVII). 
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Identity 
Other names: C10orf11, CDA017 
HGNC (Hugo): LRMDA 
Location: 10q22.3 
DNA/RNA 
Description 
In Chromosome: 10, the 1,128,715 bases long gene 
starts from 75,431,453bp from pter and ends 
76,560,167 bp from pter;  
Orientation: Plus strand. It contains 6 exons. 
Transcription 
C10orf11 encodes 16 splice variants of which 4 are 
protein coding and the remaining are processed 
transcripts. 
Protein 
Description 
The gene encodes a 198 amino acids long leucine-
rich repeat-containing protein of molecular mass 
22568 Da. 
Expression 
The gene is expressed in embryonic melanoblasts 
and fetal melanocyte and has not been detected in 
retinal pigment epithelial cells. In addition the 
expression of the gene in the following tissue types 
are evident by its existence in the corresponding 
cDNA libraries: adrenal cortex, brain, cartilage, 
cerebellum, endocrine, eye, fetus, heart, kidney, 
liver, lung, muscle, nervous, pancreas, pancreatic 
islet, placenta, pooled tissue, prostate, skin, stem 
cell, testis and uterus 
(http://cgap.nci.nih.gov/Genes/GeneInfo?ORG=Hs
CID=118161LLNO=83938). 
Localisation 
10q22.3 
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Cytogenetic band showing C10orf11 locus (http://www.genecards.org/cgi-bin/carddisp.pl?gene=C10orf11&keywords= C10orf11). 
 
Function 
The precise function of C10ORF11 is not yet known. 
However, there is some evidence that the protein 
might have a role in melanocyte differentiation. 
Mutations 
Germinal 
C10orf11 mutations are responsible for 
Oculocutaneous Albinism type 7 (OCA7). Nine 
Faroese patients and one Danish patient of 
Lithuanian origin were found to have mutations in 
C10orf11 gene representing OCAVII (Gronskov et 
al., 2014). These patients have a light skin 
pigmentation that is reported to be lighter than their 
relatives. Hair color ranges from light blond to dark 
brown. Eye findings include nystagmus, iris 
transillumination, visual acuity ranging from 6/9 to 
3/60 and very sparse peripheral ocular fundus 
pigmentation. 
Implicated in 
Breast Cancer 
To identify genetic polymorphisms associated with 
clinical outcomes of breast cancer patients with 
tamoxifen treatment, genome-wide association study 
was conducted using 462 Japanese patients with 
hormone receptor-positive, invasive breast cancer 
receiving adjuvant tamoxifen therapy. The  
study revealed that rs10509373 in C10orf11 gene to 
be significantly associated with recurrence-free 
survival in the replication study (log-rank P= 2.02 × 
10-4).  
Hazard ratio per C allele of rs10509373 was found 
to be 4.51 [95% confidence interval (CI), 2.727.51; 
P= 6.29 × 10-9].  
In a combined analysis of rs10509373 genotype with 
previously identified genetic makers, CYP2D6 and 
ABCC2, the number of risk alleles of these three 
genes was reported to have cumulative effect on 
recurrence-free survival among 345 patients 
receiving tamoxifen monotherapy (log-rank P= 2.28 
× 10-12) (Kiyotani et al., 2011). 
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